Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study
Abstract
Share and Cite
Rose, J.; Suter, F.; Furrer, E.; Sendoel, A.; Stüssi-Helbling, M.; Huber, L.C. Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study. Diagnostics 2022, 12, 1109. https://doi.org/10.3390/diagnostics12051109
Rose J, Suter F, Furrer E, Sendoel A, Stüssi-Helbling M, Huber LC. Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study. Diagnostics. 2022; 12(5):1109. https://doi.org/10.3390/diagnostics12051109
Chicago/Turabian StyleRose, Jutta, Flurina Suter, Eva Furrer, Ataman Sendoel, Melina Stüssi-Helbling, and Lars C. Huber. 2022. "Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study" Diagnostics 12, no. 5: 1109. https://doi.org/10.3390/diagnostics12051109
APA StyleRose, J., Suter, F., Furrer, E., Sendoel, A., Stüssi-Helbling, M., & Huber, L. C. (2022). Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study. Diagnostics, 12(5), 1109. https://doi.org/10.3390/diagnostics12051109

